Additional file 2 of Step up to triple therapy versus switch to dual bronchodilator therapy in patients with COPD on an inhaled corticosteroid/long-acting β2-agonist: post-hoc analyses of KRONOS
Supplementary Material 2: Additional file 2: This document contains a visual summary of the study, including key takeaway points from the background, methods, results and conclusions
Institutions
- AstraZeneca (United Kingdom) (GB)
- King's College London (GB)
- University of Manchester (GB)
- AstraZeneca (Sweden) (SE)
- AstraZeneca (Spain) (ES)
- AstraZeneca (United States) (US)
Publication Details
- Journal
- Figshare
- Published
- 2025-01-01
- DOI
- https://doi.org/10.6084/m9.figshare.29151502.v1
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00